There are 2934 resources available
Proffered Paper 1 – Gastrointestinal tumours, colorectal - Invited Discussant LBA30_PR and 522O
Presenter: Clara Montagut Viladot
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Slides
Proffered Paper – Haematological malignancies & pediatric oncology - Invited Discussant 1065O and 1066O
Presenter: Anastasios Stathis
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Slides
Webcast
Proffered Paper – Haematological malignancies & pediatric oncology - Invited Discussant LBA64 and 1067O
Presenter: Stefan Bielack
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Slides
Webcast
861 - Suppression of KRAS-G12D and BRAF-V600E Oncogene Transcription with PNA-conjugates
Presenter: Jeffrey Rothman
Session: Proffered Paper session - Basic Science
Resources:
Abstract
Slides
Webcast
4714 - Strategic inhibition of CEP55 in aggressive breast cancer leads to mitotic catastrophe
Presenter: Debottam Sinha
Session: Proffered Paper session - Basic Science
Resources:
Abstract
Slides
Webcast
4136 - The m(6)A Methyltransferase METTL3 promotes gastric cancer progression through facilitating primary microRNA maturation
Presenter: Yiting Sun
Session: Proffered Paper session - Basic Science
Resources:
Abstract
Slides
Webcast
4O - Novel Dendritic Cell based Immunotherapy for Advanced Cancer
Presenter: Aanchal Kaur
Session: Proffered Paper session - Basic Science
Resources:
Abstract
Slides
Webcast
4627 - Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)
Presenter: Antonio González Martín
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
3955 - Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev
Presenter: Isabelle Ray-Coquard
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
2772 - VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC)
Presenter: Robert Coleman
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast